Technical Analysis for HYPR - Hyperfine, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Volume Surge | Other | 7.19% | |
Lower Bollinger Band Walk | Weakness | 7.19% | |
New Downtrend | Bearish | 10.95% | |
Calm After Storm | Range Contraction | 10.95% | |
NR7 | Range Contraction | 10.95% | |
NR7-2 | Range Contraction | 10.95% | |
Lower Bollinger Band Walk | Weakness | 10.95% | |
Lower Bollinger Band Touch | Weakness | 10.95% | |
180 Bearish Setup | Bearish Swing Setup | 14.17% | |
Calm After Storm | Range Contraction | 14.17% |
Alert | Time |
---|---|
1.5x Volume Pace | 1 minute ago |
Rose Above 20 DMA | 37 minutes ago |
20 DMA Resistance | about 1 hour ago |
Up 5% | about 1 hour ago |
Up 3% | about 1 hour ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Hyperfine was founded with a vision to save lives by making Magnetic Resonance Imaging (MRI) more accessible and affordable. Hyperfine's portable Swoop™ system is the world's first FDA-cleared bedside MRI system. Hyperfine was founded in 2014 by Jonathan Rothberg, Ph.D., a serial entrepreneur and the founder or co-founder of numerous other innovative companies, including CuraGen, 454 Life Sciences, Ion Torrent, RainDance Technologies, ClariFI, Quantum-Si, AI Therapeutics, Butterfly Network, 4Catalyzer, and 4Bionics. In 2015, Rothberg was awarded the National Medal of Technology and Innovation by President Obama for inventing and commercializing DNA sequencing.
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.42 |
52 Week Low | 0.7613 |
Average Volume | 82,962 |
200-Day Moving Average | 0.99 |
50-Day Moving Average | 0.98 |
20-Day Moving Average | 0.94 |
10-Day Moving Average | 0.90 |
Average True Range | 0.05 |
RSI (14) | 43.18 |
ADX | 25.73 |
+DI | 11.95 |
-DI | 24.06 |
Chandelier Exit (Long, 3 ATRs) | 0.87 |
Chandelier Exit (Short, 3 ATRs) | 0.97 |
Upper Bollinger Bands | 1.03 |
Lower Bollinger Band | 0.84 |
Percent B (%b) | 0.29 |
BandWidth | 20.14 |
MACD Line | -0.03 |
MACD Signal Line | -0.03 |
MACD Histogram | -0.006 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.97 | ||||
Resistance 3 (R3) | 0.96 | 0.93 | 0.96 | ||
Resistance 2 (R2) | 0.93 | 0.91 | 0.94 | 0.95 | |
Resistance 1 (R1) | 0.92 | 0.90 | 0.92 | 0.92 | 0.95 |
Pivot Point | 0.88 | 0.88 | 0.89 | 0.89 | 0.88 |
Support 1 (S1) | 0.87 | 0.87 | 0.88 | 0.88 | 0.85 |
Support 2 (S2) | 0.84 | 0.86 | 0.84 | 0.85 | |
Support 3 (S3) | 0.82 | 0.84 | 0.84 | ||
Support 4 (S4) | 0.83 |